Conference Support for 16th International Workshop on KSHV and Related Agents, Pu

第 16 届 KSHV 及相关药物国际研讨会会议支持，浦

基本信息

批准号：
8541332
负责人：
Bala Chandran
金额：
$ 0.7万
依托单位：
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-05-01 至 2014-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8541332
关键词：
AIDS/HIV problem Advisory Committees African Animal Model Animals Antiviral Agents Applications Grants Area Attention Biology Biotechnology Canada Chicago China Chronic Clinical Commit Communities Country Data Development Diagnostic Disease Educational workshop Elderly Epidemiology Europe Fees Fibromatoses Finland Fostering Foundations France Funding Gene Expression Geographic Locations Germany Goals Group Meetings HIV Herpesviridae Herpesviridae Infections Human Human Herpesvirus 4 Human Herpesvirus 8 Immune Immune response Immunocompromised Host Immunosuppression Individual Infection International Intervention Israel Italy Kaposi Sarcoma Knowledge Location Lymphomagenesis Macaca mulatta Malignant Neoplasms Medicine Methods Mexico Mission Molecular Molecular Biology Multicentric Angiofollicular Lymphoid Hyperplasia Murine herpesvirus 68 National Institute of Allergy and Infectious Disease National Institute of Dental and Craniofacial Research Oral Participant Pathogenesis Pathology Pharmacologic Substance Population Postdoctoral Fellow Prevention Rare Diseases Reagent Request for Applications Research Research Personnel Retroperitoneal Space Rhadinovirus Risk Role Running Safety Saimiriine Herpesvirus 2 Scandinavia Science Scientist Site South America Therapeutic Travel United Kingdom United States National Institutes of Health Universities Vaccines Validation Viral Viral Genes Viral Pathogenesis Virus Woman abstracting blood bank contamination cancer therapy cost data exchange gammaherpesvirus man medical schools meetings member men neoplastic nonhuman primate novel oncology posters pre-doctoral primary effusion lymphoma programs public health relevance reactivation from latency research and development symposium tumor tumorigenesis tumorigenic viral detection volunteer working group

AIDS/HIV problem Advisory Committees African Animal Model Animals Antiviral Agents Applications Grants Area Attention Biology Biotechnology Canada Chicago China Chronic Clinical Commit Communities Country Data Development Diagnostic Disease Educational workshop Elderly Epidemiology Europe Fees Fibromatoses Finland Fostering Foundations France Funding Gene Expression Geographic Locations Germany Goals Group Meetings HIV Herpesviridae Herpesviridae Infections Human Human Herpesvirus 4 Human Herpesvirus 8 Immune Immune response Immunocompromised Host Immunosuppression Individual Infection International Intervention Israel Italy Kaposi Sarcoma Knowledge Location Lymphomagenesis Macaca mulatta Malignant Neoplasms Medicine Methods Mexico Mission Molecular Molecular Biology Multicentric Angiofollicular Lymphoid Hyperplasia Murine herpesvirus 68 National Institute of Allergy and Infectious Disease National Institute of Dental and Craniofacial Research Oral Participant Pathogenesis Pathology Pharmacologic Substance Population Postdoctoral Fellow Prevention Rare Diseases Reagent Request for Applications Research Research Personnel Retroperitoneal Space Rhadinovirus Risk Role Running Safety Saimiriine Herpesvirus 2 Scandinavia Science Scientist Site South America Therapeutic Travel United Kingdom United States National Institutes of Health Universities Vaccines Validation Viral Viral Genes Viral Pathogenesis Virus Woman abstracting blood bank contamination cancer therapy cost data exchange gammaherpesvirus man medical schools meetings member men neoplastic nonhuman primate novel oncology posters pre-doctoral primary effusion lymphoma programs public health relevance reactivation from latency research and development symposium tumor tumorigenesis tumorigenic viral detection volunteer working group

展开

项目摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma herpesvirus (KSHV) is the most recently identified tumorigenic herpesvirus infecting man. KSHV is the etiologic agent of Kaposi's sarcoma (KS), primary effusion lymphoma and multicentric Castleman's disease. KS is a multifocal tumor observed in elderly Mediterranean men, the immunocompromised and untreated HIV-infected individuals. It is the most frequent tumor of HIV-infected individuals and is the leading human cancer in sub- Saharan African countries. This "16th International Workshop on KSHV and Related Agents" is an annual meeting for research scientists from around the world studying all aspects of the biology of KSHV and related agents. The objective of this meeting is that scientists will share their recent findings, network and collaborate. Contributions to the meeting from groups working on related gammaherpesviruses are also expected. These viruses include others infecting humans (Epstein Barr virus) and those infecting animals, such as murine herpesvirus- 68, rhesus rhadinovirus and herpesvirus saimiri. The meeting will run for four days and will cover aspects such as clinical settings, epidemiology, pathology, treatment/Intervention, molecular biology, molecular mechanisms of tumorigenesis, and immune evasion. This conference grant application requests funds to reduce the travel and registration costs to US pre-and post- doctoral trainees in viral oncology. Delegates: The scientific program advisory committee consists of three members of local organizing committee and 19 other members. Five of the members are from abroad (Europe/China), and six of them are women. The entire committee represents diverse scientific expertise, geographic location and institutional affiliations. It is also predicted that there will be a diverse group of participants/delegates in attendance, as determined by attendance at the previous meeting in from 1999-2012. In addition to USA delegates, participants are anticipated from the United Kingdom, Canada, China, Finland, France, Germany, Italy, Israel, Mexico, Scandinavia and South America. Meeting location and dates: The meeting will be held on June 30-July 3, 2013 at the Fiesta Americana Hotel, Puerto Vallarta, Mexico.

描述（由申请人提供）：Kaposi的肉瘤疱疹病毒（KSHV）是最近确定的肿瘤疱疹病毒感染者。 KSHV是Kaposi的肉瘤（KS），原发性淋巴瘤和多中心骑员氏病的病因学药物。 KS是在老年地中海男性（免疫功能低下且未经治疗的HIV感染者）中观察到的多灶性肿瘤。它是艾滋病毒感染者最常见的肿瘤，是撒哈拉以南非洲国家领先的人类癌症。这个“第16届KSHV及相关代理商的国际研讨会”是针对来自世界各地的研究科学家的年度会议，研究KSHV及相关代理商生物学的各个方面。这次会议的目的是科学家将分享他们最近的发现，网络和协作。预计还可以从研究相关伽马病毒的小组的会议贡献。这些病毒包括其他感染人类的病毒（爱泼斯坦巴尔病毒）和那些感染动物的人，例如鼠疱疹病毒68，鼠尾草病毒和疱疹病毒saimiri。这次会议将持续四天，并将涵盖临床环境，流行病学，病理学，治疗/干预，分子生物学，肿瘤发生的分子机制和免疫逃避。该会议赠款申请要求资金减少病毒肿瘤学前和博士学位学员的旅行和注册费用。代表：科学计划咨询委员会由地方组织委员会和其他19个成员组成。其中五名成员来自国外（欧洲/中国），其中六名是女性。整个委员会代表了多样化的科学专业知识，地理位置和机构隶属关系。还可以预测，由1999年至2012年上一次会议的出席确定，将会有各种各样的参与者/代表参加。除美国代表外，还可以从英国，加拿大，中国，芬兰，法国，德国，意大利，以色列，墨西哥，斯堪的纳维亚半岛和南美参加参与者。会议地点和日期：会议将于2013年6月30日至7月3日在墨西哥瓦拉尔塔省菲亚特达美国酒店举行。